SV2B定义了一个突触囊泡子群
Isabelle Paulussen1,2, Hannes Beckert3, Timothy F Musial3
1Synaptic Neuroscience Team, Department of Neurosurgery, University Hospital Bonn, Bonn 53127, Germany.
Journal of molecular cell biology
|September 8, 2023
概括
突触囊泡蛋白 SV2A 和 SV2B 呈现出不同的突触内分布. 突触囊泡蛋白的这种空间分离影响突触功能,并可能解释SV2A.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 突触囊泡经历各种异位细胞异位细胞,内细胞异位细胞和贩运.
- 囊泡蛋白质的组成可能会决定突触囊泡的命运.
- 了解突触囊泡蛋白分布对于突触功能至关重要.
研究的目的:
- 绘制海马体质突触中的突触囊蛋白SV2A和SV2B的内突触分布.
- 调查SV2A和SV2B空间分离的功能影响.
- 确定SV2B在突触囊泡释放和发作易感性中的作用.
主要方法:
- 使用三维电子显微镜可视化SV2A和SV2B分布.
- 在停靠区,近活动区和活跃区域内分析囊泡种群.
- 在SV2B绝杀小鼠中评估发作诱导值.
主要成果:
- 在活动区附近的接囊泡中,SV2B在很大程度上缺席,而SV2A则在整个突触中存在.
- 在周活动区的膜上观察到SV2A和SV2B,这表明回收.
- 在高频刺激模型中,SV2B淘汰小鼠的发作值增加.
结论:
- 海马体的谷氨质突触产生分子上不同的突触囊泡群.
- 突触囊泡蛋白质的的空间梯度在突触内保持.
- 从活性区囊泡中缺少SV2B可能解释了SV2A在囊泡释放中的更大重要性.
相关概念视频
Overview of Secretory Vesicles
8.6K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.6K
Fusion of Secretory Vesicles with the Plasma Membrane
11.1K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
11.1K
Vesicular Tubular Clusters
2.5K
After budding out from the ER membrane, some COPII vesicles lose their coat and fuse with one another to form larger vesicles and interconnected tubules called vesicular tubular clusters or VTCs. These clusters constitute a compartment at the ER-Golgi interface known as ERGIC (Endoplasmic Reticulum Golgi Intermediate Compartment). The ERGIC is a mobile membrane-bound cargo transport system that sorts proteins secreted from ER and delivers them to the Golgi.
With the help of motor proteins such...
With the help of motor proteins such...
2.5K
Intralumenal Vesicles and Multivesicular Bodies
3.6K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.6K
SNAREs and Membrane Fusion
11.0K
Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
11.0K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
339
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
339


